May 9th, 2011
Office
Cytovance Biologics announced in March a growth equity investment of $22.5 million from Great Point Partners, LLC of Greenwich Connecticut, a private investment firm.
This investment allowes Cytovance to expand its presence in the Presbyterian Health Foundation Research Park by 27,986 SF to 67,986 SF.
Cytovance is a full service contract manufacturer of microbial biologics for biotechnology and pharmaceutical companies. Cytovance specializes in the production of therapeutic proteins and monoclonal antibodies from a mammalian and microbial cell cultures.
